Total prostatectomy for clinically localized XXXX : long-term surgical results and current morbidity.

@entity1 @entity64 @entity263 @entity190 @entity204 @entity130 @entity3142
The outcome for the first 57 successive @entity1 who underwent total perineal prostatectomy for clinically localized @entity263 at the Virginia Mason Clinic and who have been followed up for a minimum of 15 years is reviewed for evaluation of the long-term impact of this operation on the disease. Twenty percent of the @entity1 had pathologic stage C disease. Recurrence developed in 11 of the 55 @entity1 (20%) who could be evaluated, and @entity204 from @entity263 occurred in 6 (11%) during this interval. The actual observed overall survival at 15 years or more was 60%, the actuarial survival 67%, and the cause-specific survival 89%. The current morbidity of this operation was evaluated by review of the last 50 consecutive @entity1 who underwent this procedure and had follow-up of at least 6 months. Operative time averaged 140 minutes, and @entity190 averaged 660 ml; 22% of the @entity1 required a transfusion. Average postoperative hospitalization was 5 days. Two @entity1 required a temporary colostomy for unrecognized @entity130 , and 2 developed a stricture requiring more than one dilation. Three @entity1 (6%) wear pads for mild @entity3142 . One @entity1 died of a @entity64 .
